Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Johnson and Johnson
Moodys
Cerilliant
Dow
US Army
AstraZeneca
McKesson
Federal Trade Commission
UBS

Generated: February 21, 2018

DrugPatentWatch Database Preview

SEROMYCIN Drug Profile

« Back to Dashboard

When do Seromycin patents expire, and when can generic versions of Seromycin launch?

Seromycin is a drug marketed by Purdue Gmp and is included in one NDA.

The generic ingredient in SEROMYCIN is cycloserine. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cycloserine profile page.

US Patents and Regulatory Information for SEROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Gmp SEROMYCIN cycloserine CAPSULE;ORAL 060593-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
US Army
McKinsey
Boehringer Ingelheim
Harvard Business School
Dow
Cipla
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot